THE SCIENCE BEHIND THE WORLD'S LEADING ORAL PROBIOTICS

Explore our clinical studies to see why over 1 billion doses of BLIS® probiotics have been trusted globally.

STRAIN-SPECIFIC EVIDENCE YOU CAN RELY ON

BLIS Technologies is a global pioneer in oral probiotics.

Backed by more than 110 studies and 40+ clinical trials, our precision strains — including S. salivarius BLIS M18™ and S. salivarius BLIS K12™ — are proven to support immune health, fresh breath, and periodontal wellness.

Whether you’re in R&D, product development or regulatory, this is your shortcut to the science that sets BLIS apart.

The Original. The Proven. The Trusted.

One of the key factors likely to be driving BLIS M18™ improvements to periodontal health is its ability to inhibit the growth of the main driver of periodontal disease, P. gingivalis.

BLIS M18™ significantly enhanced gum health and oral hygiene in young adults with gingivitis over just 4 weeks.

BLIS M18™ significantly improved the FV hygiene index and caries stabilization (ICDAS-II) index by 2.2 and 2.3 times, respectively. Caries decreased by 81%, and the gingivitis (PMA) index dropped by 72.9%